Dublin-based Neuromod has raised €10.5m and plans to further fuel Lenire's commercialisation in Europe and reach US veterans.

Irish medtech company Neuromod has raised €10m in equity financing to expand the production of Lenire – a device that helps ...

Neuromod Devices Ltd. raised €10 million (US$10.9 million) in financing to expand the reach of Lenire, which treats tinnitus.

Irish medical device company Neuromod Devices has received €10m ($10.8m) in equity financing to broaden the reach of Lenire, ...

Dublin-based company has developed an FDA-approved device called Lenire that is for use with patients suffering from tinnitus ...

Neuromod Devices announced today that it closed an equity financing round worth proceeds of about $10.9 million (€10 million) ...

Irish medtech group Neuromod Devices has raised €10 million equity financing to expand the availability of its tinnitus ...

Neuromod has closed a €10m round of equity financing as it looks to expand the availability of its tinnitus treatment device ...

OsteoCentric Technologies, a global leader in innovative medical technologies, announced it has entered into a non-exclusive licensing agreement with Globus Medical, Inc., a leading musculoskeletal ...

Neuromod Devices Ltd. (Neuromod), an Irish medical device company specialising in tinnitus, has successfully closed a ?10 million equity financing to expand the availability of its tinnitus treatment ...